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Coronary air embolism is a potential complication of cardiopulmonary 
bypass. We compared left ventricular function before and after the admin- 
istration of antegrade or retrograde cardioplegic solution in a porcine 
model of coronary air embolism. Nineteen pigs were placed on cardiopull 
monary bypass upport and cooled to 32 ° C. The heart was initially arrested 
with antegrade cold blood cardioplegic solution. The aortic crossclamp was 
released at 30 minutes and 0.02 cc/kg body weight of air was injected into 
the left anterior descending artery distal to the first diagonal branch. After 
5 minutes the aorta was reclamped and the animals treated with 15 ml/kg 
body weight of 1:4 blood cardioplegic solution delivered by the antegrade 
(n = 6) or retrograde (n = 7) method. Control animals (n = 6) were not 
treated. Changes in regional preload recruitable stroke work were used to 
assess left ventricular performance before and after cardiopulmonary 
bypass. Two control animals could not be weaned from cardiopulmonary 
bypass. Left ventricular function was best preserved after treatment of 
induced coronary air embolism with retrograde cardioplegia (90% of 
baseline). Coronary air embolism treatment with antegrade cardioplegia 
resulted in diminished left ventricular performance (68% of baseline). In 
control animals left ventricular contractility was significantly impaired 
(39% of baseline). We conclude that administration f retrograde car- 
dioplegic solution may be an effective method of treating coronary air 
embolism. The favorable outcome seen with cardioplegia may be in part 
because of its ability to protect he ischemic myocardium while the solution 
mechanically dislodges air from the vascular bed. (J Thorac Cardiovasc 
Surg 1997;113:917-22) 
I t is recognized that arterial air embolism is haz- ardous and may result in permanent organ inju- 
ry)  -9 Coronary air embolism (CAE), a potential 
complication of cardiopulmonary bypass (CPB), 
may cause cardiac arrhythmia, myocardial infarc- 
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tion, low cardiac output syndrome, intractable ven- 
tricular fibrillation, and death. 6' 8-10 Present thera- 
peutic options for acquired CAE in the operating 
room focus on its prevention by mechanical deairing 
of the heart and great vessels before release of the 
aortic crossclamp. In one study Spiess and associates 9 
demonstrated that pretreatment with the per- 
fluorocarbon emulsion FC-43 may protect he myocar- 
dium from the sequelae of CAE in a spontaneously 
perfusing dog model. Although the idea is tempting, 
pretreatment of all patients undergoing cardiac oper- 
ations with perfluorocarbon emulsion FC-43 is imprac- 
tical. Others have advocated the use of pharmacologic 
agents, mechanical systole, and extracorporeal circula- 
tion to raise mean arterial pressure in an effort to 
dislodge air from the coronary vasculature. 6-8 Interpre- 
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Fig. 1. Diagram illustrating the instrumentation f hearts in experimental nimals. SVC, Superior vena 
cava; RA, right atrium;/VC, inferior vena cava; PA, pulmonary artery; LAD, left anterior descending; circ, 
circumflex; LA, left atrium. 
tation of results with these modalities is difficult, 
although all claim variable success, increasing myocar- 
dial oxygen demand in an already ischemic myocar- 
dium may exacerbate injury. We hypothesized that 
administration of retrograde cardioplegic solution, via 
the coronary sinus, might effectively eliminate air 
embolism from the coronary circulation and preserve 
myocardial function. 
Methods 
Surgical preparation. Nineteen domestic pigs of either 
sex (45 to 60 kg) were anesthetized with an intramuscular 
injection of ketamine (20 mg/kg), glycopyrrolate (0.01 
mg/kg), and acepromazine (0.5 mg/kg). The animals were 
intubated and the lungs mechanically ventilated with a 
volume-cycled ventilator. Anesthesia was maintained with 
inhalation of isoflurane (1.5% to 2.5%) and oxygen. The 
electrocardiogram, heart rate, and mean arterial blood 
pressure were continuously monitored throughout he 
experiment. After median sternotomy and pericardiotomy 
the heart and great vessels were exposed. The superior 
and inferior venae cavae were isolated and ensnared. The 
heart was instrumented as follows (Fig. 1). A 5F micro- 
manometer-tipped catheter (MPC 500-5F, Millar Instru- 
ments, Inc., Houston, Tex.) was introduced into the left 
ventricle (LV) via the apex to measure LV pressure. An 
injection catheter was placed in the right atrium through 
the right atrial appendage and a thermodilution catheter 
was inserted into the main pulmonary artery for cardiac 
output determinations. Another catheter was inserted into 
the left atrium through the left atrial appendage for 
methylene blue stain injection. Two pairs of piezoelectric 
sonomicrometry crystals (Triton Technology Inc., San 
Diego, Calif.), spaced approximately 1 cm apart, were 
imbedded into the midmyocardium in the regions sup- 
plied by the left anterior descending artery (LAD) (area at 
risk) and left circumflex artery (area not at risk). Deter- 
mination of the area t risk was accomplished by rapidly 
injecting dilute methylene blue stain (100 mg in 20 ml 
0.9% saline solution) into the left atrium while tempo- 
rarily (<30 seconds) occluding the LAD. 11 Baseline he- 
modynamic and LV function data were collected during 
steady-state conditions before CPB. Caval snares were 
used to vary preload during LV function data collection. 12 
After systemic heparinization (300 IU/kg) the animals 
were cannulated for CPB (Fig. 1). The ascending aorta 
was cannulated with an angled arterial cannula (Sarns, 
Ann Arbor, Mich.) and the right atrium was cannulated 
with a single dual-stage venous cannula (Biomedicus, 
Minneapolis, Minn.). The extracorporeal circuit consist- 
ing of a roller pump, membrane oxygenator (Medtronic- 
Minimax, Minneapolis, Minn.), and water bath heat ex- 
changer (Sarns TCM) was primed with 1 L each of 
Plasma-Lyte solution and 6% hetastarch (Hespan). CPB 
was instituted and the animals cooled to 32 ° C. Mechan- 
ical ventilation was discontinued and anesthesia was main- 
tained with isoflurane and oxygen via the oxygenator. 
Protocol. Animals were divided into three groups: an- 
tegrade (n = 6), retrograde (n = 7), and control (n = 6). 
Two animals were excluded from the study because of 
pneumonia discovered after median sternotomy. Experi- 
ments were randomized. Induced CAE was treated with 
cardioplegic solution delivered via the aortic root in the 
antegrade group and via the coronary sinus in the retro- 
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Fig. 2. Data demonstrate statistically significant decrease in rPRSW after induced CAE in control 
animals, but not in treated animals. Additionally, postembolism rPRSW values were significantly ower in 
control animals compared with those in animals in the retrograde group. Data shown as means plus or 
m~nus the standard eviation. *p = 0.0017 compared with baseline values; ?p = 0.0159 compared with 
retrograde group. 
grade group. The aortic root was not vented during 
retrograde administration f cardioplegic solution. Con- 
trol animals were not treated. Mean arterial perfusion 
pressures during CPB before and after CAE were main- 
tained higher than 60 mm Hg in all experiments. Fifteen 
minutes after CPB was begun, and during steady-state 
conditions, all hearts were initially arrested for 30 minutes 
with antegrade cardioplegic solution (15 ml/kg body 
weight) of 1 part blood to 4 parts crystalloid solution 
delivered at 4 ° C. This was done largely to mimic the 
clinical scenario; however, it also facilitated further instru- 
mentation of the heart. With the heart arrested a 24-gauge 
catheter was inserted into the LAD just distal to its first 
diagonal branch. Additionally, the coronary sinus was 
cannulated after ligation of the azygos vein in the retro- 
grade group. The azygos vein was ligated to ensure that 
delivered retrograde cardioplegic solution was distributed 
to the heart, because in pigs this vein drains into the 
coronary sinus. Ligation of the azygos vein was thought 
not to have any significant physiologic effects and there- 
fore was only done for retrograde-group animals. 
After 30 minutes the aortic crossclamp was removed 
and 0.02 cc/kg body weight of air was simultaneously 
injected into the LAD. Immediate blanching of the LAD 
and its branches after air injection confirmed successful 
CAE. Experimental studies have established 0.02 cc/kg of 
air in the coronary arteries as an appropriate dose to 
cause significant myocardial injury with acceptable mor- 
tality ratesf' 9, 13, ~4 Bretylium (5 mg/kg) was administered 
prophylactically to each animal before crossclamp re- 
lease. 15 The heart was allowed to reperfuse for 5 minutes 
before any therapeutic ntervention was attempted. Ani- 
mals in the antegrade and retrograde groups underwent 
Table I. LV function data before and after induced 
CAE in area at risk 
Pre-CPB Post-CPB 
rPRSW (erg • cm 3. 10 3) 
No treatment (n = 4) 73 _+ 18 29.45 _+ 14.86"? 
Antegrade (n = 6) 108 _+ 39 63 _+ 37 
Retrograde (n = 7) 62 _+ 30 51 _+ 38 
SF (%) 
No treatment (n = 4) 15.25 _+ 4.57 5 _+ 5.83 
Antegrade (n - 6) 16.71 + 9.12 13 -- 13.46 
Retrograde (n - 7) 17.28 _+ 9.69 3.86 _+ 16.83 
Values given as mean plus or minus the standard eviation; n - 19. SF, 
Segment shortening. 
*p = 0.0017 compared with baseline values. 
+p 0.0159 compared with retrograde group. 
reclamping and were treated with hypothermic (4° C) 1:4 
blood/crystalloid cardioplegic solution (15 ml/kg) via the 
aortic root (at 150 mm Hg) and coronary sinus (50 mm 
Hg), respectively. The mean cardioplegic solution admin- 
istration time was 4.29 +_ 1.38 minutes for antegrade and 
4.86 _+ 1.07 minutes for retrograde delivery. The aortic 
crossclamp was removed immediately after the treatment 
dose of cardioplegic solution was completely infused. 
Control animals did not undergo reclamping. All animals 
were rewarmed and weaned from CPB with use of a single 
vasopressor agent (norepinephrine 0.05 to 0.15/xg/kg per 
minute). The pressor equirements and support intervals 
during rewarming varied in all groups. Animals in the 
retrograde and antegrade groups were easily weaned from 
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Table II. LV function data before and after 
induced CAE in area not at risk 
Pre-CPB Post-CPB 
rPRSW (erg • cm -3 " 10 -3 )  
No treatment (n = 3) 86 _+ 47 95 _+ 101 
Antegrade (n = 6) 93 -+ 39 81 _+ 38 
Retrograde (n = 7) 73 -+ 26 57 -+ 47 
SF (%) 
No treatment (n - 4) 11.75 _+ 4.92 5 _+ 3.16 
Antegrade (n = 6) 17 _+ 3.55 10.43 _+ 8.85 
Retrograde (n = 7) 10.28 -+ 7.43 12 -+ 8.14 
Values given as mean plus or minus the standard eviation; n = 19. SF, 
segment shortening. 
CPB with minimal support in 14 _+ 6.68 and 21 _+ 7.53 
minutes, respectively. In contrast, he mean support inter- 
val for control animals was 37 +- 14.24 minutes. Data were 
collected again during steady-state conditions after dis- 
continuation of CPB. 
Data analysis. Data were digitized in real time at 200 
Hz on a multichannel analog-digital converter (MacLab/8, 
ADInstruments, Pty., Ltd.) after being filtered by a 50 Hz 
low-pass analog filter and recorded on a personal com- 
puter (Macintosh IIsi, Apple Computer, Inc., Cupertino, 
Calif.). Data were analyzed with use of a specific macro 
written for commercial software (Igor, Wavemetrics, Lake 
Oswego, Ore.). 
Regional myocardial function was quantified, before 
and after CPB, by determining the regional stroke work- 
dimension relationship or regional preload recruitable 
stroke work (rPRSW). a2, 16 Preload was varied by caval 
occlusion and data from 10 beats before onset of caval 
occlusion to steady-state maximal caval occlusion were 
used to evaluate regional stroke work over a range of 
end-diastolic lengths. For each individual cycle, regional 
stroke work was defined as the area under the LV 
pressure-segment length loop during systole. The start of 
systole (end diastole) was identified as the point just 
preceding the upstroke of the LV pressure wave. The end 
of systole (end systole) was defined with use of the first 
time derivative of the LV pressure wave as previously 
described.12,16 rPRSW was then calculated as the slope of 
the regression line that best defined the relation between 
regional stroke work and end-diastolic segment length. 
Regression lines with a correlation coefficient less than 0.8 
were excluded from analysis. 
The percent fiber shortening (FS) was also determined 
and calculated as follows: 
%AFS = EDL-ESL/EDL • 100 
where EDL is end-diastolic segment length and ESL is 
end-systolic segment length. TM 16 
Heart rate and mean arterial pressure were continu- 
ously recorded throughout the experiment. Cardiac out-
put was measured by thermodilution before and after 
CPB. Only data with less than a 10% change were 
considered. 
LV function data and hemodynamic data were com- 
pared in each animal before and after CPB with each 
Table III. Hemodynamic data before and after 
induced CAE 
Pre-CPB Post-CPB 
HR (beats/min) 
No treatment 100 _+ 5.47 132 _+ 32.86 
Antegrade 93 _+ 16.35 132 _+ 24.42 
Retrograde 100.87 _+ 19.5 129.37 -+ 32.96 
MAP (mm Hg) 
No treatment 55.5 _+ 6.15 42.25 _+ 8.30 
Antegrade 53.17 _+ 11.82 40.39 _+ 14.29 
Retrograde 58 _+ 10.35 59.17 _+ 31.07 
CO (L/rain) 
No treatment 4.59 _+ 0.90 2.30 _+ 0.67"t 
Antegrade 5.19 _+ 1.14 4.03 _+_ 0.77 
Retrograde 5.03 _+ 1.76 4.62 -- 0.93 
SW (ram Hg • ml) 
No treatment 2611.19 + 1025.92 731.62 _+ 262.95 
Antegrade 3130.95 + 755.9 1223.67 _+ 286.14§ 
Retrograde 3085.26 _+ 1331.62 2221.47 _+ 962.2 
Values given as mean plus or minus the standard eviation; n = 19. HR, 
Heart  rate; MAP, mean atrial blood pressure; CO, cardiac output; SW,, 
stroke work. 
*p = 0.0002 compared with baseline values. 
tp 0.0016 compared with retrograde group. 
~:p - 0.0223 compared with baseline values. 
§p - 0.0007 compared with baseline values. 
other and with data in control animals by analysis of 
variance. A value ofp < 0.05 was considered statistically 
significant. Data are presented as the mean plus or minus 
the standard eviation. 
Experiments were performed under the regulations of the 
Institutional Animal Care and Use Committee of Columbia 
University. All animals received humane care in compliance 
with the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Results 
All treated animals were successfully weaned from 
CPB. Two untreated pigs could not be weaned from 
CPB because of intractable ventricular fibrillation in 
one and low cardiac output syndrome in the other. 
Hearts treated with retrograde cardioplegia spontane- 
ously returned to sinus rhythm without defibrillation. 
The mean dilutional hematocrit during CPB was 
22.38% +_ 4.59%. In an effort to minimize myocardial 
edema the hematocrit during CPB was maintained 
higher than 20% by fluid restriction. 
Changes in rPRSW were used to assess regional 
LV performance before and after induced CAE. 
Myocardial function was best preserved in animals 
treated with retrograde cardioplegic solution (90% 
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of baseline). Animals treated with antegrade car- 
dioplegic solution demonstrated diminished LV per- 
formance (68% of baseline) and untreated animals 
showed significantly impaired LV contractility (39% 
of baseline). 
Mean rPRSW values before the onset of CPB 
were similar in all groups: 74.83 _+ 14.21, 92.94 _+ 
41.21, and 60.22 _+ 12.16 erg. cm -3. 10 .3 in the area 
at risk and 110 _+ 41.31, 63.42 _+ 43.15, and 53.15 _+ 
19.29 erg. cm -3. 10 .3 in the area not at risk in 
animals in the untreated, antegrade, and retrograde 
groups, respectively. After induced CAE (after 
CPB), rPRSW was significantly reduced in the area 
at risk in the untreated group (29.45 _+ 14.86 
erg. cm -3 • 10 -3, p = 0.0017 compared with values 
before CPB). Additionally, when rPRSW values for 
the areas at risk after CPB were compared among 
groups, animals not treated had significantly ower 
values (p = 0.0159) than animals treated with ret- 
rograde cardioplegic solution (Fig. 2). In the areas 
not at risk, rPRSW did not significantly change from 
baseline values after induced CAE in any group 
(Tables I and II). Percent fiber shortening did not 
decrease significantly after induced CAE in any 
experimental group (Tables I and II). 
Hemodynamic data before and after CPB are 
shown in Table Ill. Values for heart rate and mean 
arterial blood pressure did not vary significantly among 
experimental groups; however, values of cardiac out- 
put fell significantly inuntreated animals (p = 0.0002). 
Additionally, values for stroke work were significantly 
reduced in animals in both the control (p = 0.0223) 
and antegrade (p = 0.0007) groups. 
Discussion 
Air embolism to the coronary vasculature is a 
potential life-threatening complication of any pro- 
cedure requiring CPB. Unfortunately, CAE is often 
undetected and diagnosed by exclusion. Myocardial 
injury from CAE results from ischemia caused by 
trapped air that blocks coronary blood flow and 
from possible ndothelial damage by intrinsic reac- 
tions that occur at the blood/air interface. I°'17 Cur- 
rent surgical practices to prevent CAE are docu- 
mentedl-6'9'l°; however, no study to date has 
demonstrated an effective, reproducible, and safe 
method of treating CAE once it has occurred. In the 
present study we have demonstrated, with indices of 
regional myocardial function, that administration f 
retrograde cardioplegic solution after CAE may 
preserve heart function. 
The effects of air embolism have been long stud- 
ied. In 1929, Van Allen, Hrdina, and Clark 18 dem- 
onstrated that large amounts of air were required to 
cause death in dogs when injected into the venous 
circulation. In contrast, injection of small amounts 
of air into the circulation of the left side of the heart 
was noted to be lethal. Geoghegan and Lam ~ found 
1.5 cc/kg of air in the LV to be 100% fatal in dogs. 
Reduction of LV air correspondingly reduced mor- 
tality: 0.75 cc/kg and 0.5 cc/kg of air resulted in 83% 
and 33% mortality rates, respectively. Later, others 
showed that even minute amounts of air, as little as 
0.01 to 0.02 cc/kg, in the coronary arteries produced 
significant myocardial injury. 3' 8. 13 
Several experimental studies have documented 
variable success in the treatment of established 
CAE by augmenting coronary perfusion pressure to 
supernormal levels in an effort to push the air 
embolism across the capillary bed to the venous 
circulation.i, 3  4, 6, 7 Such methods have included 
mechanical systole, partial occlusion of the ascend- 
ing aorta, increasing the pump flow rate, and admin- 
istration of vasopressors and inotropic agents. Such 
techniques are potentially dangerous. The high per- 
fusion pressures required to rid the coronary arter- 
ies of air may damage ndothelium, cause interstitial 
hemorrhage, and exacerbate myocardial ischemia. 
During study of the effects of small air bubbles 
produced by laser angioplasty incoronary arteries of 
pigs, Van Blankenstein and associates I4 estimated 
that blood pressures as high as 200 mm Hg were 
required to drive air emboli through capillary vessels 
of 6 /xm in diameter. Additionally, Tuman and 
coworkers I° found that maintaining normal coro- 
nary perfusion after CAE in pigs did not signifi- 
cantly alter myocardial ischemia. 
In our study, although animals treated with ante- 
grade cardioplegic solution after CAE demon- 
strated improved cardiac function compared with 
results in untreated animals, there was significant 
evidence of residual myocardial injury. One expla- 
nation for this might be that the perfusion pressure 
of the delivered cardioplegic solution (150 mm Hg) 
might have been insufficient to adequately remove 
the CAE. In contrast, animals treated with retro- 
grade cardioplegic solution after CAE showed dra- 
matic recovery of myocardial function (90% of 
baseline). This is perhaps because retrograde car- 
dioplegia more effectively protects the heart while 
the solution mechanically dislodges air emboli and 
restores blood flow. We know from prior work that 
breaking the air lock restores forward flow of 
blood. 17 In other words it is not necessary to com- 
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pletely remove all the air f rom the vessels to rees- 
tabl ish perfus ion.  Track ing the path of  the d is lodged 
air was beyond the scope of  this study; however ,  this 
should be invest igated with contrast  echocard iogra-  
phy or microspheres .  
In summary,  we found that  CAE caused signifi- 
cant impa i rment  in reg ional  funct ion.  Admin is t ra -  
t ion of  re t rograde  card ioplegic  so lut ion was found 
to be an effective t reatment  for air embol i sm,  as 
ev idenced by preservat ion  of  reg ional  funct ion.  
These  data represent  he first ev idence that  admin-  
istrat ion of  cold b lood  re t rograde  card iop leg ic  solu- 
t ion might  offer an effect ive t reatment  for estab- 
l ished CAE and restore  cardiac funct ion to near  
basel ine levels. 
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